Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIBOFLAVIN Cause Intentional product use issue? 137 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Intentional product use issue have been filed in association with RIBOFLAVIN. This represents 16.1% of all adverse event reports for RIBOFLAVIN.

137
Reports of Intentional product use issue with RIBOFLAVIN
16.1%
of all RIBOFLAVIN reports
136
Deaths
136
Hospitalizations

How Dangerous Is Intentional product use issue From RIBOFLAVIN?

Of the 137 reports, 136 (99.3%) resulted in death, 136 (99.3%) required hospitalization, and 136 (99.3%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIBOFLAVIN. However, 137 reports have been filed with the FAERS database.

What Other Side Effects Does RIBOFLAVIN Cause?

Off label use (410) Drug ineffective (372) Nausea (271) Drug hypersensitivity (270) Product use in unapproved indication (265) Pain (264) Infusion related reaction (225) Swelling (223) Sleep disorder (214) Pericarditis (210)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which RIBOFLAVIN Alternatives Have Lower Intentional product use issue Risk?

RIBOFLAVIN vs RIBOFLAVIN 5'-PHOSPHATE RIBOFLAVIN vs RIBOFLAVIN 5^-PHOSPHATE RIBOFLAVIN vs RIFABUTIN RIBOFLAVIN vs RIFAMPICIN RIBOFLAVIN vs RIFAMPIN

Related Pages

RIBOFLAVIN Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue RIBOFLAVIN Demographics